6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Leukemia, T-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inanami, O; Kuwabara, M; Takahashi, K | 1 |
1 review(s) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Leukemia, T-Cell
Article | Year |
---|---|
Induction of apoptosis through the activation of SAPK/JNK followed by the expression of death receptor Fas in X-irradiated cells.
Topics: Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Chromans; Death Domain Receptor Signaling Adaptor Proteins; Enzyme Activation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Leukemia, T-Cell; Mitogen-Activated Protein Kinases; Receptors, Tumor Necrosis Factor; Signal Transduction; Tumor Suppressor Protein p53; X-Rays | 2003 |